ATXS
Price
$5.73
Change
+$0.30 (+5.52%)
Updated
Jul 2 closing price
Capitalization
306.44M
39 days until earnings call
GBIO
Price
$0.34
Change
+$0.02 (+6.25%)
Updated
Jul 2 closing price
Capitalization
22.65M
34 days until earnings call
Interact to see
Advertisement

ATXS vs GBIO

Header iconATXS vs GBIO Comparison
Open Charts ATXS vs GBIOBanner chart's image
Astria Therapeutics
Price$5.73
Change+$0.30 (+5.52%)
Volume$226.28K
Capitalization306.44M
Generation Bio
Price$0.34
Change+$0.02 (+6.25%)
Volume$696.32K
Capitalization22.65M
ATXS vs GBIO Comparison Chart in %
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. GBIO commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Buy and GBIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (ATXS: $5.73 vs. GBIO: $0.34)
Brand notoriety: ATXS and GBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 46% vs. GBIO: 92%
Market capitalization -- ATXS: $306.44M vs. GBIO: $22.65M
ATXS [@Biotechnology] is valued at $306.44M. GBIO’s [@Biotechnology] market capitalization is $22.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileGBIO’s FA Score has 0 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • GBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, ATXS is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 7 TA indicator(s) are bullish while GBIO’s TA Score has 4 bullish TA indicator(s).

  • ATXS’s TA Score: 7 bullish, 3 bearish.
  • GBIO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ATXS is a better buy in the short-term than GBIO.

Price Growth

ATXS (@Biotechnology) experienced а +1.42% price change this week, while GBIO (@Biotechnology) price change was -7.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +33.16%, and the average quarterly price growth was +1.56%.

Reported Earning Dates

ATXS is expected to report earnings on Aug 11, 2025.

GBIO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATXS($306M) has a higher market cap than GBIO($22.7M). ATXS YTD gains are higher at: -35.906 vs. GBIO (-68.123). GBIO has higher annual earnings (EBITDA): -69.2M vs. ATXS (-124.4M). ATXS has more cash in the bank: 295M vs. GBIO (158M). ATXS has less debt than GBIO: ATXS (5.06M) vs GBIO (87.6M). GBIO has higher revenues than ATXS: GBIO (24.6M) vs ATXS (0).
ATXSGBIOATXS / GBIO
Capitalization306M22.7M1,348%
EBITDA-124.4M-69.2M180%
Gain YTD-35.906-68.12353%
P/E RatioN/AN/A-
Revenue024.6M-
Total Cash295M158M187%
Total Debt5.06M87.6M6%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSGBIO
RSI
ODDS (%)
Bearish Trend 1 day ago
68%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 3 days ago
86%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 7 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCNAY7.96N/A
N/A
Barco NV
NAHD0.01N/A
N/A
New Asia Holdings, Inc.
HEOL15750.00N/A
N/A
Highwater Ethanol LLC
SKFOF270.57-0.39
-0.14%
Sika Finanz Ag
WEGRY16.86-0.27
-1.60%
Weir Group PLC

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with XENE. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
+5.52%
XENE - ATXS
53%
Loosely correlated
+6.61%
CRNX - ATXS
53%
Loosely correlated
+2.40%
DNLI - ATXS
52%
Loosely correlated
+6.81%
ERAS - ATXS
52%
Loosely correlated
+6.62%
COGT - ATXS
52%
Loosely correlated
+2.63%
More

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with CCCC. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
+5.59%
CCCC - GBIO
50%
Loosely correlated
+0.66%
IDYA - GBIO
49%
Loosely correlated
+3.79%
ATXS - GBIO
48%
Loosely correlated
+5.52%
FHTX - GBIO
48%
Loosely correlated
+2.26%
ATNM - GBIO
48%
Loosely correlated
+5.93%
More